Sun Strikes Deal For Clascoterone In US And Canada
Enters Into License And Supply Agreement With Italy’s Cassiopea For Winlevi
Executive Summary
Sun Pharma has expanded its dermatology portfolio by entering into a partnership with Italy’ Cassiopea to market Winlevi (clascoterone) 1% cream in the US and Canada, and expects to make it available in the US inthe fourth quarter of 2021.